Advancing metformin as a metabolic therapeutic for ovarian cancer: testing in non-diabetic patient-derived xenograft avatars

Mills, Kathryn

146
Advancing metformin as a metabolic therapeutic for ovarian cancer: testing in non-diabetic patient-derived xenograft avatars

Sunday, March 29, 2015: 3:05 PM

Salon C-D (Hilton Chicago)

K. A. Mills¹, M. A. Becker², T. Febbraro¹, L. M. Litchfield¹, E. Lengyel¹, P. Haluska Jr.² and I. Romero¹
¹University of Chicago Medicine, Chicago, IL, ²Mayo Clinic College of Medicine, Rochester, MN

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

146
Advancing metformin as a metabolic therapeutic for ovarian cancer: testing in non-diabetic patient-derived xenograft avatars

146 Advancing metformin as a metabolic therapeutic for ovarian cancer: testing in non-diabetic patient-derived xenograft avatars

146
Advancing metformin as a metabolic therapeutic for ovarian cancer: testing in non-diabetic patient-derived xenograft avatars